Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

innovator biological agent – biosimilar – immunogenicity

Switching from originator biological agents to biosimilars: what is the evidence and what are the issues?
Eric Toussirot, Hubert Marotte

RMD Open Sep 2017, 3 (2) e000492; DOI: 10.1136/rmdopen-2017-000492